Sanofi Shuts Down Bladder Cancer Drug Production: Inevitable Drug Shortage To Harm Patients

Yesterday, in a public relations email full of misplaced platitudes, Sanofi Pasteur informed urologists that they had given up making BCG. I would cite a website or news-wire but that (surprise!) does…
Read the full story: Forbes Real Time